GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights
BackgroundRecently, a novel programmed cell death mechanism, Cuproptosis, has been discovered and found to play an important role in the development and progression of diverse tumors. In the present study, we comprehensively investigated the core gene of this mechanism, GLS, in breast cancer.Materia...
Main Authors: | Danfeng Zhang, Man Wang, Xufeng Huang, Longbin Wang, Ying Liu, Shujing Zhou, Yidan Tang, Qi Wang, Zhengrui Li, Geng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1220038/full |
Similar Items
-
Machine learning‐based identification of cuproptosis‐related markers and immune infiltration in severe community‐acquired pneumonia
by: Shuyang Chen, et al.
Published: (2023-07-01) -
Commentary: Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
by: Fangshi Xu, et al.
Published: (2023-08-01) -
A novel cuproptosis-related diagnostic gene signature and differential expression validation in atherosclerosis
by: Yuting Cui, et al.
Published: (2023-07-01) -
The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma
by: Weichen Wang, et al.
Published: (2022-08-01) -
Construction and validation of a cuproptosis-related diagnostic gene signature for atrial fibrillation based on ensemble learning
by: Yixin Wang, et al.
Published: (2023-08-01)